•
Sep 30, 2024

Selecta Biosciences Q4 2024 Earnings Report

Expected Revenue:$100K
-98.3% YoY
Expected EPS:-$0.83
+7.8% YoY
Total Revenue
$387K
Previous year: $8.27M
-95.3%
Cash and Equivalents
$219M
Previous year: $76.9M
+185.0%
Free Cash Flow
$7.49M
Previous year: -$23.4M
-132.1%
Total Assets
$455M
Previous year: $305M
+49.3%

Selecta Biosciences

Selecta Biosciences